OVERVIEW

Gamechangers: Aspirin De-prescribing in Patients Taking Anticoagulants (Pharmacist) is organized by Connect Educate Impact (CEI).

Release Date: October 24, 2022
Planned Expiration Date: October 24, 2023

Credit: 0.05 CEU

Description:
The role of anticoagulant therapy (warfarin) with antiplatelet therapy (aspirin) is a balance of risk versus benefit. However, reducing risk by de-prescribing is often avoided due to hypothetical efficacy reduction. Join host, Geoff Wall, as he evaluates de-prescribing aspirin in patients taking anticoagulants.

Objectives:
Upon successful completion of this course, learners should be able to:
• Discuss indications for cardioprotective aspirin in patients taking anticoagulants
• Describe drawbacks to implementing the findings of the Schaefer et al study to a general patient population using anticoagulants

Credits
  • 0.05 CEU
  • TARGET AUDIENCE

    Pharmacist

    SPECIALITIES

    Pharmacy and Medicine

    RELATED ONLINE COURSES

    Apr 04, 2022 - Nov 30, 2026 | Webcast

    State required course for Alabama ...
    6 AMA PRA Category 1 Credits™
    ...
    More actions
    US$246

    May 16, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$50.05

    May 16, 2022 - Dec 31, 2027 | Webcast

    State required course for South Carolina
    2 AMA PRA Category 1 Credits™
    ...
    More actions
    US$94.73